Shanghai Bensen Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Bensen Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase I, Open-Label, Dose Escalation and Cohort Expansion Study of BS HH 002.SA in Patients With AML and MDS (NCT04743115) | Shanghai Bensen Pharmaceutical Co., Ltd. | 2021-02-01 |
Track Shanghai Bensen Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.